Evidence map›Paper›PMID 38608806›Full record

ArticleTransplantation and cellular therapy2024

Recruitment and Retention of Hematopoietic Cell Transplantation and Cellular Therapy Physicians: A Report from the ASTCT Talent Acquisition Task Force.

Akshay Sharma, Agnieszka Czechowicz, Melissa Mavers, Nelson Chao, John DiPersio, Pavan Reddy, Miguel-Angel Perales, Melody Smith

Open access · greenAbstract read
In one paragraph

Article in Transplantation and cellular therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. A 17-Year Experience of a Large Dedicated Fellowship in Blood and Marrow Transplantation and Cellular Therapy: A Blueprint for Modern Day Training Program.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Akshay SharmaDepartment of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
Agnieszka CzechowiczDivision of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
Melissa MaversDivision of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
Nelson ChaoDivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.
John DiPersioDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
Pavan ReddyTransplantation and Cellular Therapy Program, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Miguel-Angel PeralesAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Melody SmithDivision of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, California. Electronic address: melodysm@stanford.edu.
Washington University in St. Louis · USDuke University · USMemorial Sloan Kettering Cancer Center · USStanford Blood Center · USStanford University · USSt. Jude Children's Research Hospital · USUniversity of Michigan · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SUZANNE J. BAKER · 1985 to 2026
$166.9M
Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell diseaseU01HL163983 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Akshay Sharma, Shengdar Tsai · 2023 to 2026
$4.9M
Investigating immunophenotype and metabolism of TCR KO donor and third-party CD19-targeted chimeric antigen receptor T cellsK08HL156082 · NHLBI · STANFORD UNIVERSITY · PI SMITH, MELODY · 2021 to 2025
$835k
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA021765NHLBI NIH HHS K08 HL156082NHLBI NIH HHS U01 HL163983
6 · The paper itself

Abstract

A shortage of transplant and cellular therapy (TCT) physicians is expected given the expansion of TCT indications and the scope of practice of TCT programs in recent years. American Society of Transplantation and Cellular Therapy (ASTCT) conducted a survey of early career transplant physicians and trainees to assess the factors that prompted them to pursue to career in TCT. This was a cross-sectional survey conducted via emails sent to the ASTCT membership. Fifty-nine respondents completed the survey. The vast majority of respondents decided to pursue a career in TCT during their hematology/oncology fellowship (41%), followed by during residency (25%) or medical school (18%), and a majority of them had some exposure to TCT in their clinical training already. The most common reason for choosing to specialize in TCT was interest in the clinical practice of TCT (81%) closely followed by the scientific allure of the field (75%). Most respondents were extremely committed to remaining in this field of practice. We found that those in the field report high levels of satisfaction despite factors that would otherwise predispose them to burnout. A systematic and sustained effort to promote trainee engagement that could result in improved recruitment and retention in the field of TCT is needed. Professional societies in partnership with educational institutions could conduct outreach and help attract trainees from diverse backgrounds.

Indexed as

Hematopoietic Stem Cell TransplantationPhysiciansAdultAdvisory CommitteesCareer ChoiceCell- and Tissue-Based TherapyCross-Sectional StudiesFemaleHumansMaleSocieties, MedicalSurveys and QuestionnairesUnited StatesRecruitmentRetentionTask forceTransplant and cellular therapyWorkforce

Identifiers

PMID38608806
PMCPMC11216222
OpenAlexW4394789554

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.